Shoe Carnival's low P/E ratio is due to declining earnings and market expectations of this trend continuing. Weak future earnings growth may further decrease the P/E ratio if profitability doesn't improve, limiting potential share price growth.
Shoe Carnival's optimistic future outlook isn't fully reflected in its current share price, suggesting it may be undervalued. Consider other factors like capital structure before investing.
The insider transactions suggest optimism about Shoe Carnival's stock, indicating that insiders are quite bullish about the company. The high level of insider ownership suggests that management incentives are well aligned with other shareholders.
Despite a surge in Shoe Carnival’s share price, its P/E ratio remains under the market median due to dampened growth forecasts. This indicates that investors foresee limited future growth and are prepared to pay a lowered price for the stock, curbing the stock's potential for significant appreciation in near future.
Pre-Market Stock Movers Gapping up $Best Buy (BBY.US)$stock rose 1.1% after the electronics retailer reported a smaller-than-expected drop in quarterly comparable sales, as deeper discounts encouraged consumers to shop. $Verizon (VZ.US)$stock rose 1.5% and AT&T (NYSE:T) stock climbed 1.7% after Citigroup upgraded both telecom giants to ‘buy’ from ‘neutral’, saying they support their dividend yields. $Oracle (ORCL.US)$st...
Shoe Carnival Stock Forum
Gapping up
$Best Buy (BBY.US)$ stock rose 1.1% after the electronics retailer reported a smaller-than-expected drop in quarterly comparable sales, as deeper discounts encouraged consumers to shop.
$Verizon (VZ.US)$ stock rose 1.5% and AT&T (NYSE:T) stock climbed 1.7% after Citigroup upgraded both telecom giants to ‘buy’ from ‘neutral’, saying they support their dividend yields.
$Oracle (ORCL.US)$ st...
In reaction to earnings/guidance:
• $United Natural Foods (UNFI.US)$ +2.8%, $Grab Holdings (GRAB.US)$ +1.8% (guidance update), $Splunk (SPLK.US)$ +0.9% (reaffirms guidance; also CFO to depart co)
Select ETFs showing strength:
• IWM+1.5%,QQQ+1.4%,SPY+1.3%,DIA+1%
Other news:
• $Ocular Therapeutix (OCUL.US)$ +11.4% (reports interim 7-month data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD)
• $Symbotic (SYM.US)$ +8.4% (UN...
Here is what I have for tomorrow...
$H&R Block (HRB.US)$ will be reporting 271% growth expected to exceed .37/share earnings. right now is the time to get in aftermarket.
No comment yet